National, July 27, 2022: ASG Eye Hospitals, India’s leading eye hospital chain, today announced an INR 1,500 cr. investment led by General Atlantic and Kedaara Capital, representing India’s largest fundraise in the eye care industry and largest private equity transaction in the single specialty healthcare industry to date. General Atlantic and Kedaara Capital will join existing operations-focused healthcare investor Foundation Holdings in supporting and fuelling ASG Eye Hospitals’ growth towards their mission to become one of Asia’s leading eye hospital chains. The transaction is also expected to pave the way for an exit for Investcorp, who invested in the company in 2017. Over the last 3 years, ASG has doubled its number of hospitals and tripled its revenue.

Dr Arun Singhvi, Chairman and Managing Director and Dr Shilpi Gang, Co-Founder, ASG Hospital Pvt. Ltd. said, “Since 2005, ASG Eye Hospitals’ doctor-led model has stood for clinical excellence and quality eye-care for all. We have been fortunate to work with like-minded, value-additive investors like Foundation Holdings that have been true partners and have strengthened our model, allowing for our expansion across India to establish over 50 hospitals. We are delighted and excited to welcome General Atlantic and Kedaara Capital on our mission to enhance the delivery of quality eye care for all and improve quality of life across India. This cornerstone investment is a testament to the strength of our business model and further reinforces ASG Eye Hospitals’ continued success at attracting talented investors. We also express our sincere appreciation to the Investcorp team for their strategic support over the past 5 years.”  


Aakash Sachdev, Co-Founder and Managing Director, Foundation Holdings said, “Dr. Singhvi, Dr. Gang and the team have built ASG Eye Hospitals into a uniquely capable platform that is at the forefront of eye care in India today and has impacted millions of lives. We have successfully worked together to deliver robust growth through a mix of organic and inorganic initiatives focused on the addition of quality capacity to rapidly scale the retail healthcare delivery model across India. This fundraise is expected to accelerate the realization of ASG Eye Hospitals’ vision to become one of Asia’s preeminent eye care provider, with plans to establish a network of over 200 hospitals within the next 36 months. With the imminent planned acquisition in South India and our high-quality M&A pipeline of regional players spanning key markets across the country, we are excited to welcome and partner with two highly regarded and forward-thinking investors at this transformational inflection point in the history of ASG Eye Hospitals.”


According to the Lancet Global Health Commission’s report on global eye health, 62 million people in India are estimated to be visually impaired, with 8 million being afflicted with blindness. Cataract and diabetic retinopathy are the major causes of ocular morbidity and blindness if not treated in time. With timely medical intervention on behalf of providers like ASG Eye Hospitals, the number of complete vision loss cases could be reduced dramatically. There is a shortage of ophthalmologists and optometrists in smaller   cities,   towns,   and   rural   areas   –   India   has   only   an   estimated 25,000 ophthalmologists and only 45,000 optometrists against a required 125,000. Expanding infrastructure, training eye specialists and better utilization of technological innovation in eye-care will be essential in stemming the rising number of cases, and ASG Eye Hospitals’ expertise is anticipated to play a vital role in achieving progress across India.


Shantanu Rastogi, Managing Director at General Atlantic, said, “General Atlantic has followed ASG Eye Hospitals for several years, and we are strongly encouraged by Drs. Singhvi and Gang’s commitment to clinical rigor and quality, grounded in academic research and training. ASG Eye Hospitals has already had a positive impact on millions of lives and in the process, the team has demonstrated its ability to deliver strong performance at scale. We are excited to back the ASG team in their journey towards becoming not only a leading national provider for eye-care services in the country, but also a partner of choice for the country’s most skilled ophthalmologists and medical professionals.

Nishant Sharma, CIO & Managing Partner of Kedaara Capital said, ASG has built a unique replicable model to provide quality and affordable eye care to underserved masses across India, driven by its culture of clinical excellence and entrepreneurial passion. We are excited to team up with Dr. Singhvi, Dr.Gang and the ASG team to bring exceptional capabilities, innovation, technology-powered approach, and commitment to improving eye-health in India. Kedaara, with its operational expertise, will support ASG to bolster its next phase of growth and realize the vision of becoming the leading eye care franchise

Gaurav Sharma, Head of Private Equity, Investcorp India said, We backed Dr Arun Singhvi’s vision for ASG Eye Hospitals in 2017 when it was largely a Rajasthan-focused eye-care are chain. Today, I am delighted to say that ASG has exceeded our expectations with their execution to become one of India’s leading Eye Care Chain with presence across the length and breadth of the country. ASG has made quality eye-care available to millions of people during this period. We are incredibly proud of our association with ASG and would like to wish them the best for the future as they continue to grow from strength to strength.

ICICI Securities acted as the exclusive financial advisor for the transaction. AZB & Partners as legal counsel to ASG Eye Hospitals. Khaitan & Co. acted as legal counsel to Foundation Holdings and InvestCorp, Shardul Amarchand Mangaldas & Co acted as legal counsel to General Atlantic and Veritas Legal acted as legal counsel to Kedaara Capital.